Source:http://linkedlifedata.com/resource/pubmed/id/20734221
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2010-11-5
|
pubmed:abstractText |
Vascular endothelial growth factor-C (VEGF-C) has a well-defined action on neoplastic lymphangiogenesis and angiogenesis through VEGF receptor-3 (VEGFR-3) and VEGFR-2, respectively, which are generally expressed in endothelial cells. The function of the VEGF-C/receptors pathway in tumor cell types is largely unknown. In this study, we examined the expression and role of VEGF-C/receptors in gallbladder cancer (GBC) cells. We examined the expression of VEGF-C in 50 surgical specimens from gallbladder cancer and three human gallbladder cancer cell lines. Both siRNA and neutralizing antibody to deplete the expression of VEGF-C were used to characterize the biological effect of VEGF-C in GBC NOZ cells. Furthermore, we examined the expression of its receptors, VEGFR-3 and VEGFR-2, in three human GBC cell lines. Our results are as follows: The expression of VEGF-C in the invasive marginal portion was significantly higher than the expression in the central portions. All the three GBC cell lines expressed VEGF-C. Treatment of NOZ cells with VEGF-C siRNA or a neutralizing antibody suppressed cell proliferation and invasion. Moreover, all the three GBC cell lines expressed VEGFR3, but only the NOZ cells expressed VEGFR-2 mRNA. Treatment of NOZ cells with a VEGFR-3 neutralizing antibody suppressed cell invasion, but treatment of NOZ cells with a VEGFR-2 neutralizing antibody suppressed cell proliferation and invasion. In conclusion, GBC cells express both VEGF-C and its receptors. VEGF-C may have a role in the progressive growth and invasion of human GBC through an autocrine mechanism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor C,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor...,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1573-4919
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
345
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
77-89
|
pubmed:meshHeading |
pubmed-meshheading:20734221-Autocrine Communication,
pubmed-meshheading:20734221-Biopsy,
pubmed-meshheading:20734221-Cell Line, Tumor,
pubmed-meshheading:20734221-Cell Proliferation,
pubmed-meshheading:20734221-Disease Progression,
pubmed-meshheading:20734221-Gallbladder Neoplasms,
pubmed-meshheading:20734221-Humans,
pubmed-meshheading:20734221-Neoplasm Invasiveness,
pubmed-meshheading:20734221-RNA, Small Interfering,
pubmed-meshheading:20734221-Vascular Endothelial Growth Factor C,
pubmed-meshheading:20734221-Vascular Endothelial Growth Factor Receptor-2,
pubmed-meshheading:20734221-Vascular Endothelial Growth Factor Receptor-3
|
pubmed:year |
2010
|
pubmed:articleTitle |
Vascular endothelial growth factor-C promotes the growth and invasion of gallbladder cancer via an autocrine mechanism.
|
pubmed:affiliation |
Hepatobiliary Surgery Institute, Union Hospital, Fujian Medical University, Fuzhou, 350001, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|